The current capital of the pharmaceutical company is BGN 64.3 million.

Tchaikapharma High Quality Medicines Inc. announced that following the entry in the Commercial Register the capital of the company was increased by BGN 7.7 million, the announcement came through the BSE-Sofia.

The current capital of the pharmaceutical company is BGN 64.3 million, divided into 64.3 million dematerialized shares with a nominal value of BGN 1 each. Each share entitles to one vote at the General Meeting of Shareholders, the right to a dividend and a liquidation share of the company’s assets.

Since the beginning of the year, the shares of Tchaikapharma have appreciated by 8.32% and in the last one year the growth was 20.80% at market capitalization of BGN 427.33 million

You can read the entire article in Bulgarian here.